Phase IV Clinical Study Evaluating The Efficacy of Chemoradiotherapy Following Neoadjuvant Treatment With Docetaxel and Cisplatin in Indifferentiated and Non-Keratinized Squamous Cell Carcinoma of Nasopharynx.
Phase of Trial: Phase IV
Latest Information Update: 09 Dec 2009
At a glance
- Drugs Cisplatin; Docetaxel
- Indications Nasopharyngeal cancer
- Focus Therapeutic Use
- Acronyms Tax-Nazo
- Sponsors Sanofi
- 22 May 2009 Primary endpoint changed from disease free survival to complete clinical response rate as reported by ClinicalTrials.gov.
- 09 Nov 2008 New trial record.